MagForce AG
MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment …
Medical - Instruments & Supplies
DE, Berlin [HQ]
Cash Flow Statement
13 Sheets · From 2021 to 2009Configuration
In Million EUR. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Cash Flow (OCF) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Operating Cash (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Accounts Receivable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Accounts Payable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other WC | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Investing Activities | ||||||||||||||
| Used Cash (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Capital Expenditure | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Purchases of Investments | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Sale/Maturity of Investment | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Property, Plant, Equipment (P&PE) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Investing Activities | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Financing Activities | ||||||||||||||
| Used Cash (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Cash Balances | ||||||||||||||
| Begin of Period | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| End of Period | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Non-Cash Balances | ||||||||||||||
| Depreciation and Amortization | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Stock Based Compensation | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Highlighted metrics | ||||||||||||||
| Free Cash Flow (FCF) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Cash Conversion Cycle (CCC) | - - | - - | -1,870.00 | - - | - - | - - | 482.00 | 324.00 | 196.00 | 3,961.00 | 2,826.00 | 868.00 | 644.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |